Paul Mahon
2019
In 2019, Paul Mahon earned a total compensation of $16.6M as Executive Vice Presidentand General Counsel at United Therapeutics, a 213% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $3,038,484 |
|---|---|
| Non-Equity Incentive Plan | $690,625 |
| Option Awards | $12,003,000 |
| Salary | $812,692 |
| Other | $22,000 |
| Total | $16,566,801 |
Mahon received $12M in option awards, accounting for 72% of the total pay in 2019.
Mahon also received $3M of change in pension value and nonqualified deferred compensation earnings, $690.6K in non-equity incentive plan, $812.7K in salary and $22K in other compensation.
Rankings
In 2019, Paul Mahon's compensation ranked 277th out of 13,971 executives tracked by ExecPay. In other words, Mahon earned more than 98.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 277 out of 13,971 | 98th |
Division Manufacturing | 97 out of 5,692 | 98th |
Major group Chemicals And Allied Products | 26 out of 2,189 | 99th |
Industry group Drugs | 22 out of 1,875 | 99th |
Industry Pharmaceutical Preparations | 19 out of 1,387 | 99th |
Source: SEC filing on April 29, 2022.
Mahon's colleagues
We found three more compensation records of executives who worked with Paul Mahon at United Therapeutics in 2019.